Latest Updates

Pharma gives UCPMP the thumbs up, health activists cry foul

Read more

GLP1 agonists set to become the best-selling drugs in 2024: GlobalData

Read more

Syngene biologics facility to be operational for US, European customers from mid-year

Read more

Biocon Biologics sells branded formulations biz to Eris Lifesciences for INR12.42 bn

Read more

Biomarkers becoming important for approval of ALS therapies: GlobalData

Read more

USV opens new facility in Baddi

Read more

Sanofi India, Emcure Pharma announce exclusive distribution partnership

Read more

Zydus launches IBYRA, the generic version of Olaparib

Read more

IIT Kanpur study unveil insights into working mechanism of cholesterol lowering drugs

Read more

Biotech funding set for recovery in 2024: GlobalData

Read more